Arecor Therapeutics annual net profit margin
2022
2023
2024
2025
Arecor Therapeutics Net Profit Margin Growth & History (AREC)
Arecor Therapeutics's net profit margin was 38.74% for fiscal 2025.
View full Arecor Therapeutics company overviewArecor Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 38.74% | +661.75 pp |
| 2024 | 2024-12-31 | −623.01% | −435.95 pp |
| 2023 | 2023-12-31 | −187.05% | +198.30 pp |
| 2022 | 2022-12-31 | −385.35% | — |
Arecor Therapeutics net profit margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Arecor Therapeutics's net profit margin increased from −385.35% to 38.74%, a change of +424.09 percentage points.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as reported net income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arecor Therapeutics source filings ↗Community posts
Arecor conditionally raises £5 million to extend insulin-development funding
Arecor Therapeutics ($AREC-LSE) has conditionally placed approximately 7.35 million new shares at 68 pence each, raising about £5 million before expenses. The financing follows an accelerated bookbuild and is separate from a planned retail ...
